Omnic Ocas®, Tabsulosine 0.4 mg Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Omnic Ocas®, Tabsulosine 0.4 mg Tablets, covering 2025-08-28 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State [Phase 1]